SOD1 overexpression in vivo blocks hyperglycemia-induced specific PKC isoforms: substrate activation and consequent

Xuezheng Li1, Hongbo Weng, E Albert Reece

  • 1Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.

Abstract

Insights

Mitigating oxidative stress by overexpressing superoxide dismutase 1 (SOD1) in transgenic mice blocked hyperglycemia-induced protein kinase C (PKC) activation and its downstream effects, preventing diabetic embryopathy.

Area of Science:

  • Reproductive Biology
  • Developmental Biology
  • Biochemistry

Background:

  • Oxidative stress is a key factor in diabetic embryopathy.
  • Hyperglycemia during pregnancy can lead to birth defects.
  • Protein Kinase C (PKC) signaling pathways are implicated in developmental abnormalities.

Purpose of the Study:

  • To investigate if mitigating oxidative stress can prevent hyperglycemia-induced PKC activation.
  • To determine the role of superoxide dismutase 1 (SOD1) in protecting against diabetic embryopathy.
  • To examine the downstream effects of PKC activation in diabetic embryos.

Main Methods:

  • Comparison of embryos from nondiabetic control, diabetic wild-type, and diabetic SOD1-transgenic mice.
  • Measurement of phosphorylated PKC isoforms (PKCα/βII, PKCδ) and their substrates (MARCKS, RACK1).
  • Assessment of lipid peroxidation markers (4-HNE, MDA) to quantify oxidative stress.

Main Results:

  • Diabetic embryos showed elevated levels of phosphorylated PKC isoforms and lipid peroxidation markers.
  • SOD1 overexpression in diabetic embryos normalized these markers to levels comparable to non-diabetic controls.
  • Levels of RACK1 did not differ significantly among the groups.

Conclusions:

  • Overexpression of SOD1 effectively mitigates oxidative stress in the context of maternal diabetes.
  • Reducing oxidative stress blocks hyperglycemia-induced activation of specific PKC isoforms and their downstream signaling.
  • This suggests a potential therapeutic strategy for preventing diabetic embryopathy.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...